Metabolic Syndrome Criteria Table
Nutrition & Sports Nutrition Reference Tables
Metabolic Syndrome Criteria Table
The AHA metabolic-syndrome framework requires at least three of five clinical findings; appropriate medication treatment can satisfy the corresponding criterion. Waist thresholds vary by population.
| Finding | Reference criterion | Qualification |
|---|---|---|
| Abdominal obesity | Common US waist examples: >40 in men; >35 in women | Population-specific alternatives apply |
| Triglycerides | >=150 mg/dL | Or relevant treatment |
| Low HDL-C | <40 mg/dL men; <50 mg/dL women | Or relevant treatment |
| Blood pressure | Systolic >=130 OR diastolic >=85 mmHg | Or relevant treatment |
| Fasting glucose | >=100 mg/dL | Or relevant treatment |
Metabolic Syndrome is a defined cluster of cardiometabolic risk factors, with diagnostic criteria depending on the adopted framework.
Clinical nutrition translates assessment into an individualized intervention and evaluates the response. A disease name alone cannot define the prescription: disease stage, medication, symptoms, laboratory findings, intake and functional goals matter. Screening identifies possible risk, whereas a full assessment supports a nutrition diagnosis and care plan. A sports context adds training demands but does not remove clinical requirements. Coordinate care when medical and performance objectives interact instead of applying a standard athlete menu to every patient.
Nutrition for diabetes coordinates food, activity, medication and glucose monitoring. Carbohydrate quantity matters, but food quality, distribution, total energy and individual response also require attention. People using insulin or certain glucose-lowering medicines can develop hypoglycemia, and abrupt dietary changes may require clinician-guided medication review. Carbohydrate counting describes estimation of carbohydrate intake; it is not itself an insulin prescription. Ratios, correction factors and targets are individualized and should not be borrowed from another athlete or an educational example.
Lipid management distinguishes LDL cholesterol, triglycerides, non-HDL cholesterol and other relevant markers rather than treating every abnormal result as the same problem. Dietary fat quality, fiber-containing foods, alcohol, energy balance and underlying conditions can affect different components. Medication may also be indicated according to overall cardiovascular risk. A high HDL value does not cancel elevated atherogenic risk, and changing one laboratory number does not by itself demonstrate improved clinical outcomes or superior athletic performance.
For example, an athlete can have a reassuring body weight yet still need assessment of glucose, lipids or blood pressure. Interpret the full risk pattern and relevant medical history. A single favorable marker does not cancel another abnormal result, and improved fitness does not remove the need for appropriate clinical follow-up.
Obesity is a complex chronic condition involving excess adiposity and health risk, with influences extending beyond individual choice. Body mass index is a screening measure and cannot distinguish muscle from fat or locate visceral fat. Classification thresholds and risk interpretation can differ by population. Assess waist measures, function, medical history and metabolic complications when relevant. In muscular athletes, a high body mass index alone does not justify an assumption of excessive adiposity or an automatic weight-loss prescription.
Cardioprotective eating commonly emphasizes vegetables, fruit, legumes, whole grains, nuts and suitable unsaturated-fat sources while improving the quality of fat and reducing excessive sodium. Benefits depend on what replaces the foods reduced. Clinical lipid and blood-pressure goals require broader assessment, including medication when indicated. Athletes should adapt portions and carbohydrate supply to training rather than assuming a heart-supporting pattern must be low in energy, extremely restrictive or unsuitable for fueling exercise.
Laboratory markers provide information within a clinical context rather than a complete nutrition diagnosis. Albumin and prealbumin are affected by inflammation, fluid balance, organ function and other processes, so they should not be interpreted as direct isolated measures of protein intake or muscle mass. A reference interval is not automatically the optimal target for an athlete. Combine relevant tests with intake, physical findings, symptoms and trends, and consider the method and timing before attributing a result to diet alone.
Table references: American Heart Association · 1
Home
Academy
Site Map